Back to News
Market Impact: 0.18
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit
Source: globenewswire.com
Legal & LitigationCompany Fundamentals
Regeneron (REGN) is facing a securities class action filed for shareholders who bought shares between Aug. 1, 2025 and May 15, 2026. The news is a legal overhang that can increase downside risk via potential costs and uncertainty, though no financial figures are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
REGN-0.70
More News
- Why is T-Mobile stock tumbling today?
- Why is Verizon stock sliding today?
- SpaceX wants to become a 'major mobile carrier' with low-band spectrum acquisition
- OpenAI projected to bring in $20bn less in revenue than expected
- Soitec climbs 7% as BofA turns bullish on silicon photonics demand
- Schott Pharma drops after Deutsche Bank downgrades on demanding valuation